French region slow at diagnosing colorectal cancer:
This article was originally published in Clinica
Executive Summary
Most sufferers from colorectal cancer in the Loire-Atlantique region in France are waiting too long for diagnosis. The area, which has a population of nearly one million, has the second highest incidence of colorectal cancer in France, reports Le Quotidien du Medecin. Researchers looked at 2,597 cases of the cancer over a five-year period.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.